undefined undefined
NaN.000
NaN.00%
Fortress Biotech press release (NASDAQ:FBIO): Q1 GAAP EPS of -$1.03 beats by $0.70. Revenue of $13M (+4.6% Y/Y) misses by $1.13M. Shares -0.29%. More on Fortress Biotech Journey Medical announces U.S....
05-16 04:54
Fortress Biotech, Inc. (NASDAQ:FBIO) shareholders are no doubt pleased to see t...
03-07 18:00
Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial OfficerFARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ocuphire
02-14 21:17
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
01-10 21:09
To the annoyance of some shareholders, Fortress Biotech, Inc. (NASDAQ:FBIO) sha...
01-09 06:40
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The S&P 500 also fell, dropping, 0.33% to 4,767.78.
2023-12-30 03:21
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.34% to 37,583.72 while the NASDAQ fell 0.73% to 14,984.98. The S&P 500 also fell, dropping, 0.47% to 4,760.73.
2023-12-30 01:19
Cyprium received $4.5 million payment upon closing and remains eligible to rece...
2023-12-06 09:41
MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. ...
2023-12-01 09:30
Fortress Biotech Inc (NASDAQ: FBIO) shares are trading lower by 38.5% to $1.28 Friday morning after the company announced pricing of a $10 million public offering.
2023-11-10 23:20